The conference, which is one of the largest in cardiovascular disease in the Asia/Pacific region, is expected to gather over 8,000 participants. Ina Laura Perkins has been invited by one of China's leading heart surgeons, Mr. Shenshou Hu, President of Fuwai Hospital in Beijing. With an annual caseload of 15,000 cardiac surgeries and 50,000 interventional procedures, Fuwai Hospital is one of the world's largest cardiovascular clinics.

“CHC is an extraordinary opportunity for Realheart to create contacts and build awareness of our artificial heart in China and Southeast Asia. A better introduction to these markets is hard to imagine," says Ina Laura Perkins.

In markets outside Europe and the US, such as China and Southeast Asia, Realheart intends to work with partners and distributors for marketing and sales of its total artificial heart. The markets are sizeable and comprise advanced treatments. The number of patients with heart failure is estimated at approximately 12 million in China and 9 million in Southeast Asia, which can be compared with 15 million in Europe and 6 million in the USA.

During the autumn, Realheart intends to continue the work of identifying possible partners in the region and creating initial contacts with important parties.